Astellas Gene Therapies remains intent on treating X-linked Myotubular Myopathy (XLMTM) through a gene therapy—but instead of AAV-based resamirigene bilparvovec (AT132), Astellas is now partnering ...
No gene acts alone: interacting variants and protein partnerships can worsen, mask or even rescue disease risk, demanding ...
Zeleciment basivarsen (z-basivarsen) demonstrated sustained functional improvement across multiple clinical measures in the ongoing ACHIEVE clinical trial - ...
Moderna and Merck said on Tuesday their experimental vaccine for a serious type of skin cancer, when used with Keytruda, ...
New research has revealed that many psychiatric disorders share a common genetic root, a discovery with the potential to ...
Natural cycles, a birth control and fertility app, is now offering a Whoop-style band to take temperature measurements in ...
At CES 2026, I tried six consumer exoskeletons and talked to an expert on medical exoskeletons. I'm not sure these devices ...
Jorgensen Land & Cattle hosted the 2025 Motherlode Female & Bull Sale on November 22, 2025, showcasing a lineup of registered ...
The U.S. Food and Drug Administration approved Fortress Biotech and Indian drugmaker Zydus Lifesciences' drug for children ...
Looking to plump thin lips? Get dermatologist-approved treatments, tricks, and proven makeup techniques to boost volume ...
The U.S. FDA has approved Zycubo (copper histidinate, CUTX-101) as the first treatment for Menkes disease, a rare, genetic disease affecting children who cannot absorb copper through their intestines, ...
Alignment Reached with U.S. FDA on Potential Accelerated Approval Pathway for BEAM-302 in Alpha-1 Antitrypsin Deficiency (AATD) Based on ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback